Table 3. Prospective associations of circulating inflammatory markers (CRP and IL-6) at baseline with fatigue at follow-up.
Adjustment* | CRP as predictor | IL-6 as predictor | ||||
---|---|---|---|---|---|---|
| ||||||
N | β | P | N | β | P | |
Age, sex, ethnicity (Model A) | 6658 | −0.052 | <0.001 | 6614 | −0.042 | 0.001 |
A + Socioeconomic position | 6654 | −0.052 | <0.001 | 6610 | −0.042 | 0.001 |
A + Biomedical factors | 6600 | −0.033 | 0.011 | 6559 | −0.031 | 0.013 |
A + Health-related behaviors | 6532 | −0.047 | <0.001 | 6488 | −0.035 | 0.005 |
A + Fatigue-related symptoms | 6649 | −0.046 | <0.001 | 6605 | −0.039 | 0.001 |
Fully adjusted | 6465 | −0.025 | 0.048 | 6424 | −0.025 | 0.044 |
CRP = C-reactive protein; IL-6 = interleukin-6; β = standardized regression coefficient expressing the change in standardized fatigue score per one standard deviation in log-transformed CRP or IL-6 concentration
Biomedical factors include body mass index, systolic blood pressure, presence of common medical conditions, and use of prescription medications that could affect systemic inflammatory status. Health-related behaviors include smoking and alcohol consumption. Fatigue-related symptoms include symptoms of depression/anxiety and sleep difficulty at baseline.